New US pharmaceutical tariffs may have ‘no immediate impact’ on drugmakers: DPM Gan

The tariffs – and the associated exemptions – are significant to Singapore because pharmaceutical exports to the US account for about S$4 billion of Singapore's exports, or about 13% of domestic goods exports to the US, noted DPM Gan.

https://bt.sg/KBrB